Eli Lilly to Unveil New Findings on Retatrutide and More at EASD 2026 | Retatrutide News

Eli Lilly will present new data on Retatrutide at the EASD 2026 meeting. This could enhance understanding of its role in cardiometabolic health.
Clinical Trials · October 26, 2026